$ブレインストーム セル セラピューティクス(BCLI.US)$ one could possibly read this as 1.5 million shares being shorted today. Wonder how many will lose their shorts on this one. Projected price of 2.55. Maybe I should load more.
1
報告
JCBFスレ主 :
It's more like people quit lending actually. That would be great! If people didn't lend their stocks.
Trytosaveabitスレ主Double_Bottom:
That’s a listing requirement as well that hasn’t been met yet as you see by the price! The requirement they regained was Minimum Market Value! They fall under different rules!
Trytosaveabitスレ主Double_Bottom:
BTW I answered your question a quick! I can give you a further explanation if you need/want on the several different rule/requirements for listing?
Trytosaveabitスレ主Double_Bottom:
Different NASDAQ markets have different levels of requirements! So the market this trades on, the requirements are Minimum Market Value of Listed Securities has to be at least 35 million! Then another rule/requirement is minimum 500K publicly held shares! Also the Market value of those shares has to equal 1 million! Then the rule/requirement that most are familiar with, Minimum of 1.00 per share! And there is a minimum amount of shareholders required rule/requirement! And that is 300! Theses Rules/listing requirements vary a bit Depending on the NASDAQ market listed on! Ex: GLOBAL MARKET, GLOBAL SELECT MARKET And CAPITAL MARKET! Hope this helps!
$ブレインストーム セル セラピューティクス(BCLI.US)$BrainStorm Cell Therapeutics Announces Peer-reviewed Publication of Biomarker Data from NurOwn's® Phase 3 Clinical Trial in ALS NurOwn treatment resulted in a positive impact on important CSF biomarkers relevant to ALS compared to placebo. Significant changes in multiple ALS disease pathways support NurOwn's mechanism of action and complement clinical effects observed in ALS.
JCBFスレ主 : It's more like people quit lending actually. That would be great! If people didn't lend their stocks.